Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$gild $60.0 v -0.11 (-0.18%)
Volume: 13,251,119 @01/05/21 7:59:23 PM EST
Gilead Sciences or Biogen: Which Biotech Stock is a Better Pick for 2021?
https://ih.advfn.com/stock-market/NASDAQ/gilead-sciences-GILD/stock-news/84008440/gilead-sciences-or-biogen-which-biotech-stock-is
$GILD [value and yield, consider these five undervalued dividend stocks to buy:]
Gilead Sciences (NASDAQ:GILD)
https://finance.yahoo.com/news/5-undervalued-dividend-stocks-buy-194131394.html
https://www.griproom.com/fun/it-looks-like-gilead-is-about-to-merge-with-roche
Roche is one of the worst Pharma Companies to work for.
If True, watch Gilead lose the people that got them here.
This is like Frank Lorenzo buying up Eastern Airlines snd others.
Some chat, iRoche is the one killing the stock
NIH study uncovers blood vessel damage and inflammation in COVID-19 patients’ brains but no infection
Results from a study of 19 deceased patients suggests brain damage is a byproduct of a patient’s illness.
Scan of deceased COVID-19 patient’s brain
NIH researchers consistently found blood vessel damage in the brains of COVID-19 patients but no signs of SARS-CoV-2 infections. Arrows point to light and dark spots that are indicative of blood vessel damage observed in the study. NIAID
In an in-depth study of how COVID-19 affects a patient’s brain, National Institutes of Health researchers consistently spotted hallmarks of damage caused by thinning and leaky brain blood vessels in tissue samples from patients who died shortly after contracting the disease. In addition, they saw no signs of SARS-CoV-2 in the tissue samples, suggesting the damage was not caused by a direct viral attack on the brain. The results were published as a correspondence in the New England Journal of Medicine.
“We found that the brains of patients who contract infection from SARS-CoV-2 may be susceptible to microvascular blood vessel damage. Our results suggest that this may be caused by the body’s inflammatory response to the virus” said Avindra Nath, M.D., clinical director at the NIH’s National Institute of Neurological Disorders and Stroke (NINDS) and the senior author of the study. “We hope these results will help doctors understand the full spectrum of problems patients may suffer so that we can come up with better treatments.”
https://www.nih.gov/news-events/news-releases/nih-study-uncovers-blood-vessel-damage-inflammation-covid-19-patients-brains-no-infection
They better should work together and make a hell of a combination
IPIX phase II study for Brilacidin given the green light to start WITHOUT Remdesivir. Gilead needs to buy a boarding pass or miss this flight.
Pardon a newbie for busting in here. The street is all over Gilead. It forgets that the rheumatoid arthritis treatment was approved in Europe and Japan at the same time it was being held-up here. The street is also quite critical of the high-priced buyouts of these cancer research companies. I have followed this company for a long time and am interested in your feedback.
$gild $60.77 ^ 0.32 (0.53%)
Volume: 7,845,100 @12/11/20 7:59:47 PM EST
GILD acquires—(private)—MYR DmbH for $1.4B (€1.15B) plus contingencies:
https://www.businesswire.com/news/home/20201210005315/en/Gilead-Sciences-to-Acquire-MYR-GmbH
Gilead Announces Racial Equity Community Impact Fund to Support Black Communities Across United States
https://ih.advfn.com/stock-market/NASDAQ/gilead-sciences-GILD/stock-news/83864876/gilead-announces-racial-equity-community-impact-fu
Gilead Sciences Inc (GILD)
60.63 ? -0.93 (-1.51%)
Volume: 3,657,588 @12/07/20 1:20:32 PM EST
Bid Ask Day's Range
60.62 60.63 60.41 - 61.7
GILD Detailed Quote
A dividend would be welcome as we're trading around a two year low.
Love it here for the Long haul my friend..... fantastic article
New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes
https://www.researchgate.net/publication/341456311_New_GMP_manufacturing_processes_to_obtain_thermostable_HIV-1_gp41_virosomes_under_solid_forms_for_various_mucosal_vaccination_routes
https://www.mymetics.com/media-center/new-gmp-manufacturing-processes-obtain-thermostable-hiv-1-gp41-virosomes-under-solid-forms-various-mucosal-vaccination-routes/
I believe the time of this combination will come soon, maybe half of december
Brilacidin and Remdesivir shown to act synergistically in vitro, increasing overall inhibition against the novel coronavirus to 99.85 percent in a human lung cell line
Data suggest that Brilacidin and Remdesivir, with different but complementary primary mechanisms of action, may be an especially potent combination in treating COVID-19
https://www.globenewswire.com/news-release/2020/09/15/2093822/0/en/Laboratory-Testing-of-Brilacidin-for-COVID-19-in-Combination-with-Remdesivir-Reduces-Viral-Load-by-Nearly-100-Percent.html
Good luck and GOD bless,
Remdesivir, hailed — and taken — by Trump, doesn't work for coronavirus, World Health Organization declares
https://www.yahoo.com/news/remdesivir-hailed-and-taken-by-trump-doesnt-work-for-coronavirus-world-health-organization-declares-192616230.html
Good luck and GOD bless,
Looks like Gilead will lose some market share for Remdesivir. Perhaps this will finally prompt them to partner with Innovation Pharmaceuticals for Brilacidin.
https://www.cnbc.com/2020/11/19/coronavirus-who-tells-doctors-dont-use-gileads-remdesivir-splitting-with-fda.html?__source=androidappshare&fbclid=IwAR3z4fzJHQ1-U7LEK92Jfa-6ADdoY7GL8teKHO79HV9anxPyze-QCA5ghUU
BREAKING NEWS: $GILD Gilead and Novo Nordisk Present New Data from Proof-of-Concept Trial in NASH
-- Results from First Phase 2 Trial Describing a Triple Combination Regimen Targeting NASH Presented at The Liver Meeting Digital Experience -- Gilead Sciences, Inc. (Nasdaq: GILD) and Novo Nordisk A/S (NASDAQ Copenhagen: NOVO B) today announced results from a Phase 2 pr...
Find out more GILD - Gilead and Novo Nordisk Present New Data from Proof-of-Concept Trial in NASH
$gild $60.5 ^ 0.52 (0.87%)
Volume: 6,777,255 @11/13/20 7:59:41 PM EST
Brilacidin and FDA-approved remdesivir exhibit excellent synergistic activity in vitro against SARS-CoV-2.
https://science.gmu.edu/news/innovation-pharmaceuticals-and-george-mason-university-release-laboratory-testing-results
Good luck and GOD bless,
IPIX is not a drug. It is a company. Brilacidin is their main drug that was coupled with Remdesivir.
I agree. I am sure they are giving this to a lot of people behind the scenes!
-GILD
Even with a Vaccine we will still need a therapeutic Cure.
We might test some new lows over here..
-GILD
$gild $59.12 ^ 0.05 (0.08%)
Volume: 10,791,367 @11/09/20 5:52:39 PM EST
We are not dogs prone to chase squirrels. This doesn’t change the findings for Remdesivir + Brilacidin.
You're spamming garbage on a big board.
I’m sorry but I’m not familiar with the credential your buddy holds. “Drug Designer” sounds important... possibly...
The studies highlighting Brilacidin’s effectiveness are coming from the highest bio containment government labs.
Yeah except a study with 300 peeps is a joke. Had my buddy a drug designer look into it. Said it looks like fluff.
Remdesivir should be tested in combination with brilacidin ASAP
$gild $59.0 v -0.63 (-1.06%)
Volume: 7,225,766 @11/06/20 7:59:50 PM EST
$GILD 11/03/20 Morgan Stanley Reinstates Equal-Weight $67.00
https://www.benzinga.com/stock/gild/ratings
This is what will bring the pandemic to an end. A real cure. This partnership better hurry or IPIX will steal the stage and the limelight. Brilacidin is clearly more effective than Remdesivir as a stand-alone drug and in vivo testing just around the corner.
GILD isn't "treated" as having a worldwide go to for the coronavirus
Article shows a health care worker in Hungary holding a vial of remdesivir! Seems while the “WHO study” is the only thing anyone wants to talk about, “you the investor to get scared from.” Remdesivir is becoming a worldwide go to for the coronavirus...
https://ge.usembassy.gov/u-s-approves-first-treatment-for-hospitalized-covid-19-patients/
-GILD
Mark102, quite the contrary Big Pharma does not want a cure to a problem they wish to prolong it as long as they can to make move money and cure no one. GO BPPHarm You Da Man.
I am not sure why GILD does not buy up little IPIX who has the goods and the end to this virus solved, just do it GILD go for it. You want to be the hero here, then go for it. "He Who Hesitates Is Lost".
.
https://www.news-medical.net/news/20201104/Study-shows-brilacidin-strongly-inhibits-SARS-CoV-2-in-laboratory-cell-lines.aspx
As a GILD stockholder it is you right to demand a combination trial of remdesivir with Brilacidin.
The combination of brilacidin with remdesivir was noticed to reduce the viral load by more than 99 per cent, “thus providing a highly effective inhibition profile and achieving greater inhibition than with either compound alone…”
https://theprint.in/health/investigational-drug-brilacidin-shows-efficacy-against-covid-in-lab-testing-finds-study/535032/
Good luck and GOD bless,
https://m.marketscreener.com/quote/stock/GILEAD-SCIENCES-INC-4876/news/Gilead-Sciences-Germany-says-remdesivir-useful-for-some-COVID-19-patients-31681023/
I am sure in the short term Gilead will be announcing a manufacturing deal with a company to mass produce remdesivir. WHO study still has not been peer reviewed. Insurance companies trying to get the price lower and bribing scientists affiliated with WHO? Just maybe! Why is Russia wanting remdesivir as well, since it supposedly has no benefit..
https://m.marketscreener.com/quote/stock/GILEAD-SCIENCES-INC-4876/news/Gilead-Sciences-Russian-firm-seeks-to-produce-COVID-19-drug-remdesivir-without-patent-31669292/
This drug in combination with remdesivir has shown almost 100% effectiveness. I wonder if they are tryouts no to fast track this...
https://www.globenewswire.com/news-release/2020/09/15/2093822/0/en/Laboratory-Testing-of-Brilacidin-for-COVID-19-in-Combination-with-Remdesivir-Reduces-Viral-Load-by-Nearly-100-Percent.html
“BOOM”
“HOLD ON TIGHT”
-GILD
Followers
|
164
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
4865
|
Created
|
04/30/09
|
Type
|
Free
|
Moderators |
333 Lakeside Drive
Foster City, CA 94404
PER IHUB MGMT |
02-07-2021
DISCLAIMER: ONLY FOR MICK
https://investorshub.advfn.com/boards/profilea.aspx?user=1012
*The Board Monitor and herewithin , are not licensed brokers and assume NO responsibility for actions,
investments,decisions, or messages posted on this forum.
CONTENT ON THIS FORUM SHOULD NOT BE CONSIDERED ADVISORY NOR SOLICITATION
AUTHORS MAY HAVE BUYS OR SELLS WITH THE COMPANIES MENTIONED IN TRADING POSTERS SHOULD DUE DILIGENT BUYING OR SELLING.
ALL POSTING SHOULD BE CONSIDERED FOR INFORMATION ONLY. WE DO NOT RECOMMEND ANYONE BUY OR SELL ANY SECURITIES POSTED HEREWITHIN.
ANY trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.Any
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |